Neurostimulation therapies for primary headache disorders: present and future.
about
The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic CephalalgiasTranscutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly® Device for Migraine Prevention: A Review of the Available Data.Operationalizing Cognitive Science and Technologies' Research and Development; the "Brain and Cognition Study Group (BCSG)" Initiative from Shiraz, Iran.Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experienceStimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study.Clinical utility of implantable neurostimulation devices in the treatment of chronic migraineManagement of fibromyalgia syndrome in 2016.Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.Cluster headache and other TACs: Pathophysiology and neurostimulation options.High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache.Is β endorphin related to migraine headache and its relief?[Neurostimulation for treatment of headaches].Refractory migraine: the role of the physician in assessment and treatment of a problematic disease.Repetitive Transcranial Magnetic Stimulation (rTMS)-Induced Trigeminal Autonomic Cephalalgia.Simultaneous determination of three alkaloids, four ginsenosides and limonin in the plasma of normal and headache rats after oral administration of Wu-Zhu-Yu decoction by a novel ultra fast liquid chromatography-tandem mass spectrometry method: applSphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.
P2860
Q26786375-BEC38D75-6F9F-400D-BDF7-E5CEC8DAB7F8Q31005037-7476F7EE-127D-45A6-A630-7685D41D5980Q34368128-BAEF16AB-4071-4AAD-98C8-938A3F05D5C9Q35876316-355FE931-F644-4374-B645-A8EAC24814ECQ37047300-D7DF92B2-E94A-4DC8-B423-5E8FB083EB5CQ37338058-CDFD0FCA-CE2E-447F-B3EB-67E422B5A88DQ37342832-C5B67214-13C8-464D-9376-792923BE81E4Q38773592-A0468838-46C2-4C60-8E06-A2A6173CFE1DQ39106338-CC05B062-FD66-4955-BAC3-CB555C2D0A7EQ39227534-19B519D1-7CD0-44EF-90B3-8AA98990F647Q39234541-B6F90C76-98D3-45DB-BBE6-2E3AC5609401Q39244750-8B3BC3DB-FEA8-47BD-996A-1F4F27645541Q39413997-05C4D57C-984F-4404-8F85-87CA5702B711Q42316086-116A36D6-8D27-489E-81DE-9474B61B570FQ43632833-76B2327F-775E-477B-BCA7-7493CB42AE1AQ55031304-FC0045AD-8FC9-4C5A-8C57-62155483F0E9
P2860
Neurostimulation therapies for primary headache disorders: present and future.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neurostimulation therapies for primary headache disorders: present and future.
@ast
Neurostimulation therapies for primary headache disorders: present and future.
@en
Neurostimulation therapies for primary headache disorders: present and future.
@nl
type
label
Neurostimulation therapies for primary headache disorders: present and future.
@ast
Neurostimulation therapies for primary headache disorders: present and future.
@en
Neurostimulation therapies for primary headache disorders: present and future.
@nl
prefLabel
Neurostimulation therapies for primary headache disorders: present and future.
@ast
Neurostimulation therapies for primary headache disorders: present and future.
@en
Neurostimulation therapies for primary headache disorders: present and future.
@nl
P50
P1476
Neurostimulation therapies for primary headache disorders: present and future.
@en
P304
P356
10.1097/WCO.0B013E3283532023
P577
2012-06-01T00:00:00Z